Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford, CA, USA.
Departmentt of Microbiology Immunology & Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium.
Allergy. 2021 Jun;76(6):1640-1660. doi: 10.1111/all.14840. Epub 2021 Jun 4.
Vaccines are essential public health tools with a favorable safety profile and prophylactic effectiveness that have historically played significant roles in reducing infectious disease burden in populations, when the majority of individuals are vaccinated. The COVID-19 vaccines are expected to have similar positive impacts on health across the globe. While serious allergic reactions to vaccines are rare, their underlying mechanisms and implications for clinical management should be considered to provide individuals with the safest care possible. In this review, we provide an overview of different types of allergic adverse reactions that can potentially occur after vaccination and individual vaccine components capable of causing the allergic adverse reactions. We present the incidence of allergic adverse reactions during clinical studies and through post-authorization and post-marketing surveillance and provide plausible causes of these reactions based on potential allergenic components present in several common vaccines. Additionally, we review implications for individual diagnosis and management and vaccine manufacturing overall. Finally, we suggest areas for future research.
疫苗是具有良好安全性和预防效果的重要公共卫生工具,在大多数人接种疫苗的情况下,它们在历史上发挥了重要作用,降低了人群中传染病的负担。预计 COVID-19 疫苗将在全球范围内对健康产生类似的积极影响。虽然疫苗严重过敏反应很少见,但应考虑其潜在机制及其对临床管理的影响,以尽可能为个人提供最安全的护理。在这篇综述中,我们概述了接种疫苗后可能发生的不同类型的过敏不良反应,以及可能导致过敏不良反应的个别疫苗成分。我们介绍了在临床研究中以及通过授权后和上市后监测期间过敏不良反应的发生率,并根据几种常见疫苗中存在的潜在变应原成分,提出了这些反应的可能原因。此外,我们还审查了对个体诊断和管理以及疫苗制造的总体影响。最后,我们提出了未来研究的领域。